Through PRENITA, Bioserve offers a range of prenatal and post-natal screening tests that provide accurate results with actionable insights, which help the clinician to analyze and provide the best outcome to the patients. PRENITA provides the most advanced Preimplantation Genetic Screening/Diagnosis (PGS/PGD), Non-Invasive Prenatal Screening Test (NIPT), Invasive Diagnostic testing… Read more

In prenatal condition, QFPCR aids in rapid diagnosis of the common chromosomal aneuploidies like 13, 18, 21 and gonosomal aneuploidies. QFPCR enables to provide the results within 24 hours and can be performed with small amount of specimen unlike microarray and Karyotyping. Karyotyping is a gold standard in providing a comprehensive cytogenetic view of the fetus but is subjected to failures due to slow growth in the culture and contamination. 

QFPCR is performed on Chorionic Villus Sampling and on Cells obtained from Amniotic Fluid

When is QFPCR used?

QFPCR is used as confirmatory diagnostic test for NIPT and Maternal Serum Screening.

Need of Rapid Diagnosis

Complements the conventional karyotype

Get in touch